Mona O Sarhan

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Escherichia Coli

Molecular Docking

Top Venues

Archiv der Pharmazie

Journal of labelled compounds & radiopharmaceuticals

This page only lists publications with an associated author ORCID identifier.

Publications

Manar M Abuzahra, Nesreen S Ahmed, Mona O Sarhan, Shahenda Mahgoub, Ahmed Abdelhameed, Wafaa A Zaghary
Novel substituted 1,8-naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition. Archiv der Pharmazie (2023)
Manar M Abuzahra, Nesreen S Ahmed, Mona O Sarhan, Shahenda Mahgoub, Ahmed Abdelhameed, Wafaa A Zaghary
Novel substituted 1,8-naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition. Archiv der Pharmazie (2023)
Manar M Abuzahra, Nesreen S Ahmed, Mona O Sarhan, Shahenda Mahgoub, Ahmed Abdelhameed, Wafaa A Zaghary
Novel substituted 1,8-naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition. Archiv der Pharmazie (2023)
Manar M Abuzahra, Nesreen S Ahmed, Mona O Sarhan, Shahenda Mahgoub, Ahmed Abdelhameed, Wafaa A Zaghary
Novel substituted 1,8-naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition. Archiv der Pharmazie (2023)
Manar M Abuzahra, Nesreen S Ahmed, Mona O Sarhan, Shahenda Mahgoub, Ahmed Abdelhameed, Wafaa A Zaghary
Novel substituted 1,8-naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition. Archiv der Pharmazie (2023)
Gamal Abdelaziz, Hesham A Shamsel-Din, Mona O Sarhan, Mohamed A Gizawy
"Tau Protein Targeting Via Radioiodinated Azure A For Brain Theranostics: Radiolabeling, Molecular Docking, in vitro And in vivo Biological Evaluation". Journal of labelled compounds & radiopharmaceuticals 63 (1) (2019)
Mohamed Abd El-Motaleb, Ismail T Ibrahim, Mona O Sarhan, Wafaa A Zaghary
Radioiodination and biological distribution of a new s-triazine derivative for tumor uptake evaluation. Journal of labelled compounds & radiopharmaceuticals 61 (14) (2018)